GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Other Current Receivables

ProKidney (MEX:PROK) Other Current Receivables : MXN31.58 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ProKidney Other Current Receivables?

ProKidney's Other Current Receivables for the quarter that ended in Mar. 2024 was MXN31.58 Mil.

ProKidney's quarterly Other Current Receivables increased from Sep. 2023 (MXN12.44 Mil) to Dec. 2023 (MXN23.34 Mil) and increased from Dec. 2023 (MXN23.34 Mil) to Mar. 2024 (MXN31.58 Mil).

ProKidney's annual Other Current Receivables stayed the same from Dec. 2021 (MXN0.00 Mil) to Dec. 2022 (MXN0.00 Mil) but then increased from Dec. 2022 (MXN0.00 Mil) to Dec. 2023 (MXN23.34 Mil).


ProKidney Other Current Receivables Historical Data

The historical data trend for ProKidney's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Other Current Receivables Chart

ProKidney Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Receivables
- - - 23.34

ProKidney Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.71 138.69 12.44 23.34 31.58

ProKidney Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


ProKidney Other Current Receivables Related Terms

Thank you for viewing the detailed overview of ProKidney's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


ProKidney (MEX:PROK) Business Description

Traded in Other Exchanges
Address
2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.